St. Louis, MO, United States of America

Judy A Diaz-Collier

This inventor holds 1 USPTO granted patent. Top assignee: Monsanto Company. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Judy A Diaz-Collier. Retrieved from https://idiyas.com/inventor/judy-a-diaz-collier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Judy A Diaz-Collier

Introduction

Judy A Diaz-Collier is an accomplished inventor based in St. Louis, MO (US). She has made significant contributions to the field of biochemistry, particularly in the production of tissue factor pathway inhibitors. Her innovative methods have the potential to impact various medical applications.

Latest Patents

Judy holds a patent for a method of producing tissue factor pathway inhibitor (TFPI). This method involves the expression of a non-glycosylated form of TFPI in E. coli as a host. The process results in a highly active TFPI through in vitro refolding of the protein. Inclusion bodies isolated from the E. coli cells undergo stepwise purification, which can follow either series (A) or series (B).

Career Highlights

Judy has been associated with Monsanto Company, where she has utilized her expertise in biochemistry to advance research and development. Her work has contributed to the understanding and production of critical proteins that play a role in various biological processes.

Collaborations

Throughout her career, Judy has collaborated with notable colleagues, including Mark E Gustafson and Tze-Chein Wun. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Judy A Diaz-Collier's contributions to the field of biochemistry through her innovative patent demonstrate her commitment to advancing scientific knowledge and applications. Her work continues to inspire future research in the area of tissue factor pathway inhibitors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…